These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16033834)

  • 1. EphB2 is a prognostic factor in colorectal cancer.
    Jubb AM; Zhong F; Bheddah S; Grabsch HI; Frantz GD; Mueller W; Kavi V; Quirke P; Polakis P; Koeppen H
    Clin Cancer Res; 2005 Jul; 11(14):5181-7. PubMed ID: 16033834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.
    Guo DL; Zhang J; Yuen ST; Tsui WY; Chan AS; Ho C; Ji J; Leung SY; Chen X
    Carcinogenesis; 2006 Mar; 27(3):454-64. PubMed ID: 16272170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.
    Lugli A; Spichtin H; Maurer R; Mirlacher M; Kiefer J; Huusko P; Azorsa D; Terracciano L; Sauter G; Kallioniemi OP; Mousses S; Tornillo L
    Clin Cancer Res; 2005 Sep; 11(18):6450-8. PubMed ID: 16166419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of EphA4 gene and reduced expression of EphB2 gene correlates with liver metastasis in colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Akihito N; Nagano Y; Fujii S; Kunisaki C; Wada N; Rino Y; Tanaka K; Masuda M; Imada T
    Int J Oncol; 2008 Sep; 33(3):573-7. PubMed ID: 18695888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
    Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
    J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Rel is a transcriptional repressor of EPHB2 in colorectal cancer.
    Fu T; Li P; Wang H; He Y; Luo D; Zhang A; Tong W; Zhang L; Liu B; Hu C
    J Pathol; 2009 Sep; 219(1):103-13. PubMed ID: 19621336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors.
    Alazzouzi H; Davalos V; Kokko A; Domingo E; Woerner SM; Wilson AJ; Konrad L; Laiho P; Espín E; Armengol M; Imai K; Yamamoto H; Mariadason JM; Gebert JF; Aaltonen LA; Schwartz S; Arango D
    Cancer Res; 2005 Nov; 65(22):10170-3. PubMed ID: 16288001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of the peripheral benzodiazepine receptor during human colorectal carcinogenesis and tumor spread.
    Maaser K; Grabowski P; Oezdem Y; Krahn A; Heine B; Stein H; Buhr H; Zeitz M; Scherübl H
    Clin Cancer Res; 2005 Mar; 11(5):1751-6. PubMed ID: 15755996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
    Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
    J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression.
    Kumar SR; Scehnet JS; Ley EJ; Singh J; Krasnoperov V; Liu R; Manchanda PK; Ladner RD; Hawes D; Weaver FA; Beart RW; Singh G; Nguyen C; Kahn M; Gill PS
    Cancer Res; 2009 May; 69(9):3736-45. PubMed ID: 19366806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis.
    Kokko A; Laiho P; Lehtonen R; Korja S; Carvajal-Carmona LG; Järvinen H; Mecklin JP; Eng C; Schleutker J; Tomlinson IP; Vahteristo P; Aaltonen LA
    BMC Cancer; 2006 Jun; 6():145. PubMed ID: 16740153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
    Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
    Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
    Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined expression of the non-receptor protein tyrosine kinases FAK and Src in primary colorectal cancer is associated with tumor recurrence and metastasis formation.
    de Heer P; Koudijs MM; van de Velde CJ; Aalbers RI; Tollenaar RA; Putter H; Morreau J; van de Water B; Kuppen PJ
    Eur J Surg Oncol; 2008 Nov; 34(11):1253-61. PubMed ID: 18556171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2).
    Schulenburg A; Cech P; Herbacek I; Marian B; Wrba F; Valent P; Ulrich-Pur H
    J Pathol; 2007 Oct; 213(2):152-60. PubMed ID: 17708598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome profile of human colorectal adenomas.
    Sabates-Bellver J; Van der Flier LG; de Palo M; Cattaneo E; Maake C; Rehrauer H; Laczko E; Kurowski MA; Bujnicki JM; Menigatti M; Luz J; Ranalli TV; Gomes V; Pastorelli A; Faggiani R; Anti M; Jiricny J; Clevers H; Marra G
    Mol Cancer Res; 2007 Dec; 5(12):1263-75. PubMed ID: 18171984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significance.
    Shia J; Klimstra DS; Nitzkorski JR; Low PS; Gonen M; Landmann R; Weiser MR; Franklin WA; Prendergast FG; Murphy L; Tang LH; Temple L; Guillem JG; Wong WD; Paty PB
    Hum Pathol; 2008 Apr; 39(4):498-505. PubMed ID: 18342661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential CXC receptor expression in colorectal carcinomas.
    Rubie C; Kollmar O; Frick VO; Wagner M; Brittner B; Gräber S; Schilling MK
    Scand J Immunol; 2008 Dec; 68(6):635-44. PubMed ID: 18959627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
    Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
    Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.